Chronic insomnia is a poorly understood disorder. Risk factors for developing chronic insomnia are largely unknown, yet disturbances in arousal seem to accompany the disorder. We here investigate whether insomnia patients and control participants differ with respect to one operationalization of arousal, i.e. cortical excitability. A method to directly investigate the excitability level of the h...

Insomnia is a leading cause of absenteeism, presenteeism (lost productivity when employees are at work), accidents, and errors in the workplace. Overall direct and indirect costs exceed $30 billion annually. A significant portion of these costs are attributable to patients with comorbid insomnia, making these conditions a significant clinical public health issue. These comorbid conditions inclu...

Insomnia, the most common sleep disturbance in later life, affects 20%-50% of older adults. Eszopiclone, a short-acting nonbenzodiazepine hypnotic agent developed for the treatment of insomnia, has been available in Europe since 1992 and in the US since 2005. Although not yet evaluated for transient insomnia in older adults, eszopiclone has been shown to be safe and efficacious for short-term t...

Insomnia is a mental condition that has a profound and well-documented effect on overall health and quality of life (QOL) in the general population (Figure). In a study of a community-dwelling population, insomnia was shown to be associated with depression and dementia.3,4 Insomnia can also lead to an unhealthy lifestyle and an abnormal autonomic nervous system and neuroendocrine system,5 and t...

PURPOSE To estimate the prevalence of insomnia in patients with chronic back pain, and to correlate insomnia with severity of back pain and disability. METHODS 63 women and 57 men aged 24 to 83 (mean, 55) years who presented with chronic back pain for >6 months were asked to complete a self-administered questionnaire to evaluate the Insomnia Severity Index (ISI), Oswestry Disability Index (OD...

971 Treating acute insomnia using CBT-I—Ellis et al. INTRODUCTION Chronic insomnia is a significant public health concern and has been linked to the development and/or worsening of a number of physical and psychiatric conditions.1–6 At symptom level, between 30–48% of the population report having chronic insomnia and at syndrome level the prevalence, albeit significantly lower at between 6–15%,...

Insomnia is the most prevalent sleep disorder; especially in the elderly.1-3 It is diagnosed in women (55-60%) more often than men (40-45%).4-6 It can occur acutely (as known as transient insomnia) or become a chronic disorder (occurring at least three or more times per week, usually one to six months in duration and with some degree of daytime dysfunction).4 Epidemiological studies indicate th...

BACKGROUND Insomnia is highly prevalent among people with chronic pain conditions. Because insomnia has been shown to worsen pain, mood, and physical functioning, it could negatively impact the clinical outcomes of patients with chronic pain. OBJECTIVE To determine the risk factors associated with clinical insomnia in chronic neck pain (CNP) patients. STUDY DESIGN Retrospective analysis. ...

PRIMARY INSOMNIA, MEETING DSM-IV CRITERIA, IS A COMMON ILLNESS WITH AN ESTIMATED PREVALENCE OF 10%-15%, AND A MEDIAN DURATION OF 4 YEARS, with more than one-third of patients reporting chronicity in excess of 10 years.1-3 Cross-sectional studies, utilizing varying definitions, have found the complaint of insomnia to be associated with impaired quality of life and reduced productivity and functi...